热门出版物 - 学术资源搜索

h5 指数:90
h5 中位数:122

h5 指数是指在过去整整 5 年中所发表文章的 h 指数。h 指在 2018-2022 年间发表的 h 篇文章每篇至少都被引用过 h 次的最大值。隐藏

出版物的 h5 中位数，是指出版物的 h5 指数所涵盖的所有文章获得的引用次数的中位值。隐藏

#9 Pharmacology & Pharmacy

标题/作者	引用次数	年份
Traditional Chinese medicine for COVID-19 treatment. JL Ren, AH Zhang, XJ Wang Pharmacological Research 155, 104743-104743	496	2020
Candidate drugs against SARS-CoV-2 and COVID-19 DL McKee, A Sternberg, U Stange, S Laufer, C Naujokat Pharmacological Research 157, 104859	469	2020
Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2) L Runfeng, H Yunlong, H Jicheng, P Weiqi, M Qinhai, S Yongxia, ... Pharmacological Research 156, 104761	451	2020
The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases XC Li, J Zhang, JL Zhuo Pharmacological Research 125, 21-38	394	2017
Obesity and hypertension G Seravalle, G Grassi Pharmacological Research 122, 1-7	386	2017
Hypertension and cardiovascular risk: General aspects SE Kjeldsen Pharmacological Research 129, 95-99	337	2018
Properties of FDA-approved small molecule protein kinase inhibitors R Roskoski Jr Pharmacological Research 144, 19-50	336	2019
Properties of FDA-approved small molecule protein kinase inhibitors: A 2020 update R Roskoski Jr Pharmacological Research 152, 104609	318	2020
Physiological and pathological regulation of ACE2, the SARS-CoV-2 receptor Y Li, W Zhou, L Yang, R You Pharmacological Research 157, 104833	316	2020
Sex-and gender-related prevalence, cardiovascular risk and therapeutic approach in metabolic syndrome: A review of the literature G Pucci, R Alcidi, L Tap, F Battista, F Mattace-Raso, G Schillaci Pharmacological Research 120, 34-42	268	2017
Small molecule inhibitors targeting the EGFR/ErbB family of protein-tyrosine kinases in human cancers R Roskoski Jr Pharmacological Research 139, 395-411	231	2019
Drug repurposing in cancer L Sleire, HE Førde, IA Netland, L Leiss, BS Skeie, PØ Enger Pharmacological Research 124, 74-91	212	2017
Astaxanthin: A mechanistic review on its biological activities and health benefits S Fakhri, F Abbaszadeh, L Dargahi, M Jorjani Pharmacological Research 136, 1-20	210	2018
Cyclin-dependent protein serine/threonine kinase inhibitors as anticancer drugs R Roskoski Jr Pharmacological Research 139, 471-488	210	2019
30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: A prospective cohort study A Giacomelli, AL Ridolfo, L Milazzo, L Oreni, D Bernacchia, M Siano, ... Pharmacological Research 158, 104931	203	2020
Curcumin use in pulmonary diseases: State of the art and future perspectives D Lelli, A Sahebkar, TP Johnston, C Pedone Pharmacological Research 115, 133-148	203	2017
Canonical and non-canonical mechanisms of Nrf2 activation CA Silva-Islas, PD Maldonado Pharmacological Research 134, 92-99	182	2018
Vascular endothelial growth factor (VEGF) and VEGF receptor inhibitors in the treatment of renal cell carcinomas R Roskoski Jr Pharmacological Research 120, 116-132	174	2017
Metabotropic glutamate receptors and neurodegenerative diseases FM Ribeiro, LB Vieira, RGW Pires, RP Olmo, SSG Ferguson Pharmacological Research 115, 179-191	170	2017
Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post-treatment hospitalisation status S Antinori, MV Cossu, AL Ridolfo, R Rech, C Bonazzetti, G Pagani, ... Pharmacological Research 158, 104899	169	2020

1 - 20

计算机程序会自动估算并确定日期和引用次数。